Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07545590
PHASE1

A Study of Eltrekibart (LY3041658) in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate how eltrekibart is absorbed by the body when it is given under the skin to healthy participants. The study will last about 17 weeks.

Official title: A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and Tolerability of Two Formulations of Eltrekibart in Healthy Participants

Key Details

Gender

All

Age Range

21 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-04-21

Completion Date

2026-08

Last Updated

2026-06-23

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

LY3041658

Administered SC

DRUG

LY3041658

Administered IV

Locations (1)

Lilly Centre for Clinical Pharmacology

Singapore, Singapore